135 related articles for article (PubMed ID: 10439799)
1. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.
François C; van Velthoven R; De Lathouwer O; Moreno C; Peltier A; Kaltner H; Salmon I; Gabius HJ; Danguy A; Decaestecker C; Kiss R
Am J Clin Pathol; 1999 Aug; 112(2):194-203. PubMed ID: 10439799
[TBL] [Abstract][Full Text] [Related]
2. The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers.
Choufani G; Nagy N; Saussez S; Marchant H; Bisschop P; Burchert M; Danguy A; Louryan S; Salmon I; Gabius HJ; Kiss R; Hassid S
Cancer; 1999 Dec; 86(11):2353-63. PubMed ID: 10590378
[TBL] [Abstract][Full Text] [Related]
3. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
4. Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 and galectin-3 binding sites, but not galectin-1, in benign vs malignant uterine smooth muscle tumors.
Schwarz G; Remmelink M; Decaestecker C; Gielen I; Budel V; Burchert M; Darro F; Danguy A; Gabius HJ; Salmon I; Kiss R
Am J Clin Pathol; 1999 May; 111(5):623-31. PubMed ID: 10230352
[TBL] [Abstract][Full Text] [Related]
5. Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.
Dancer JY; Truong LD; Zhai Q; Shen SS
Arch Pathol Lab Med; 2010 Jan; 134(1):90-4. PubMed ID: 20073610
[TBL] [Abstract][Full Text] [Related]
6. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.
Camby I; Belot N; Rorive S; Lefranc F; Maurage CA; Lahm H; Kaltner H; Hadari Y; Ruchoux MM; Brotchi J; Zick Y; Salmon I; Gabius HJ; Kiss R
Brain Pathol; 2001 Jan; 11(1):12-26. PubMed ID: 11145198
[TBL] [Abstract][Full Text] [Related]
7. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
8. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
9. Galectin-9 expression as a poor prognostic factor in patients with renal cell carcinoma.
Jikuya R; Kishida T; Sakaguchi M; Yokose T; Yasui M; Hashizume A; Tatenuma T; Mizuno N; Muraoka K; Umemoto S; Kawai M; Yoshihara M; Nakamura Y; Miyagi Y; Sasada T
Cancer Immunol Immunother; 2020 Oct; 69(10):2041-2051. PubMed ID: 32424467
[TBL] [Abstract][Full Text] [Related]
10. Expression of galectin-1 and galectin-3 in renal cell carcinoma; immunohistochemical study.
Aboulhagag NA; El-Deek HEM; Sherif MF
Ann Diagn Pathol; 2018 Oct; 36():31-37. PubMed ID: 30055522
[TBL] [Abstract][Full Text] [Related]
11. Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas.
Delorge S; Saussez S; Pelc P; Devroede B; Marchant H; Burchert M; Zeng FY; Danguy A; Salmon I; Gabius HJ; Kiss R; Hassid S
Otolaryngol Head Neck Surg; 2000 Jun; 122(6):834-41. PubMed ID: 10828795
[TBL] [Abstract][Full Text] [Related]
12. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
[TBL] [Abstract][Full Text] [Related]
13. Endogenous lectins (galectins-1 and -3) as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of the oropharynx and larynx.
Plzak J; Smetana K; Betka J; Kodet R; Kaltner H; Gabius HJ
Int J Mol Med; 2000 Apr; 5(4):369-72. PubMed ID: 10719052
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.
Sanjuán X; Fernández PL; Castells A; Castronovo V; van den Brule F; Liu FT; Cardesa A; Campo E
Gastroenterology; 1997 Dec; 113(6):1906-15. PubMed ID: 9394730
[TBL] [Abstract][Full Text] [Related]
15. Sertoli cell expression of galectin-1 and -3 and accessible binding sites in normal human testis and Sertoli cell only-syndrome.
Wollina U; Schreiber G; Görnig M; Feldrappe S; Burchert M; Gabius HJ
Histol Histopathol; 1999 Jul; 14(3):779-84. PubMed ID: 10425546
[TBL] [Abstract][Full Text] [Related]
16. Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival.
Merseburger AS; Kramer MW; Hennenlotter J; Serth J; Kruck S; Gracia A; Stenzl A; Kuczyk MA
World J Urol; 2008 Dec; 26(6):637-42. PubMed ID: 18594826
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation.
Tinari N; Kuwabara I; Huflejt ME; Shen PF; Iacobelli S; Liu FT
Int J Cancer; 2001 Jan; 91(2):167-72. PubMed ID: 11146440
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis.
Gordower L; Decaestecker C; Kacem Y; Lemmers A; Gusman J; Burchert M; Danguy A; Gabius H; Salmon I; Kiss R; Camby I
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):319-30. PubMed ID: 10476049
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.
Shimazui T; Kojima T; Onozawa M; Suzuki M; Asano T; Akaza H
Oncol Rep; 2006 May; 15(5):1181-4. PubMed ID: 16596183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
